Humana (HUM) Competitors

$305.08 +9.73 (+3.30%)

Closing price 05/13/2026 03:59 PM Eastern

Extended Trading

$305.00 -0.08 (-0.03%)

As of 08:31 AM Eastern

HUM vs. CI, CNC, ELV, MOH, and UNH

Should you buy Humana stock or one of its competitors? MarketBeat compares Humana with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Humana include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), and UnitedHealth Group (UNH). These companies are all part of the "managed health care" industry.

How does Humana compare to Cigna Group?

Humana (NYSE:HUM) and Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends.

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.2%. Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.1%. Humana pays out 37.9% of its earnings in the form of a dividend. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Humana has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market. Comparatively, Cigna Group has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market.

Cigna Group has a net margin of 2.26% compared to Humana's net margin of 0.82%. Cigna Group's return on equity of 19.75% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Cigna Group	2.26%	19.75%	5.30%

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$137.20B	0.27	$1.19B	$9.35	32.63
Cigna Group	$278.13B	0.29	$5.96B	$23.59	12.73

Humana presently has a consensus price target of $246.83, indicating a potential downside of 19.10%. Cigna Group has a consensus price target of $338.35, indicating a potential upside of 12.65%. Given Cigna Group's stronger consensus rating and higher possible upside, analysts clearly believe Cigna Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	4 Sell rating(s)	15 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.12
Cigna Group	0 Sell rating(s)	4 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.86

In the previous week, Humana had 1 more articles in the media than Cigna Group. MarketBeat recorded 14 mentions for Humana and 13 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.19 beat Humana's score of 0.80 indicating that Cigna Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	7 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cigna Group	9 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.4% of Humana shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 0.2% of Humana shares are held by insiders. Comparatively, 0.6% of Cigna Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Cigna Group beats Humana on 16 of the 20 factors compared between the two stocks.

How does Humana compare to Centene?

Humana (NYSE:HUM) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

Humana has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, Centene has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market.

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Centene	-3.25%	5.57%	1.54%

Humana has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$137.20B	0.27	$1.19B	$9.35	32.63
Centene	$194.78B	0.15	-$6.67B	-$13.14	N/A

Humana currently has a consensus target price of $246.83, suggesting a potential downside of 19.10%. Centene has a consensus target price of $53.82, suggesting a potential downside of 8.32%. Given Centene's stronger consensus rating and higher probable upside, analysts clearly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	4 Sell rating(s)	15 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.12
Centene	2 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.32

In the previous week, Humana had 6 more articles in the media than Centene. MarketBeat recorded 14 mentions for Humana and 8 mentions for Centene. Centene's average media sentiment score of 0.95 beat Humana's score of 0.80 indicating that Centene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	7 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.4% of Humana shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Humana beats Centene on 9 of the 17 factors compared between the two stocks.

How does Humana compare to Elevance Health?

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$137.20B	0.27	$1.19B	$9.35	32.63
Elevance Health	$200.42B	0.43	$5.66B	$23.51	16.98

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.2%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Humana pays out 37.9% of its earnings in the form of a dividend. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Elevance Health has a net margin of 2.62% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 15.58% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Elevance Health	2.62%	15.58%	5.57%

Humana has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market.

92.4% of Humana shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.2% of Humana shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Humana currently has a consensus target price of $246.83, suggesting a potential downside of 19.10%. Elevance Health has a consensus target price of $384.58, suggesting a potential downside of 3.69%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	4 Sell rating(s)	15 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.12
Elevance Health	0 Sell rating(s)	10 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.57

In the previous week, Elevance Health had 9 more articles in the media than Humana. MarketBeat recorded 23 mentions for Elevance Health and 14 mentions for Humana. Humana's average media sentiment score of 0.80 beat Elevance Health's score of 0.62 indicating that Humana is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	7 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	11 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Elevance Health beats Humana on 15 of the 19 factors compared between the two stocks.

How does Humana compare to Molina Healthcare?

Humana (NYSE:HUM) and Molina Healthcare (NYSE:MOH) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

In the previous week, Molina Healthcare had 27 more articles in the media than Humana. MarketBeat recorded 41 mentions for Molina Healthcare and 14 mentions for Humana. Humana's average media sentiment score of 0.80 beat Molina Healthcare's score of 0.50 indicating that Humana is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	7 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Molina Healthcare	13 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market.

92.4% of Humana shares are held by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are held by institutional investors. 0.2% of Humana shares are held by company insiders. Comparatively, 1.4% of Molina Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Humana presently has a consensus target price of $246.83, suggesting a potential downside of 19.10%. Molina Healthcare has a consensus target price of $174.53, suggesting a potential downside of 9.15%. Given Molina Healthcare's higher probable upside, analysts clearly believe Molina Healthcare is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	4 Sell rating(s)	15 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.12
Molina Healthcare	2 Sell rating(s)	11 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06

Humana has higher revenue and earnings than Molina Healthcare. Humana is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$137.20B	0.27	$1.19B	$9.35	32.63
Molina Healthcare	$45.43B	0.22	$472M	$3.38	56.84

Humana has a net margin of 0.82% compared to Molina Healthcare's net margin of 0.42%. Humana's return on equity of 10.45% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Molina Healthcare	0.42%	8.76%	2.32%

Summary

Humana beats Molina Healthcare on 10 of the 16 factors compared between the two stocks.

How does Humana compare to UnitedHealth Group?

Humana (NYSE:HUM) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Humana presently has a consensus target price of $246.83, suggesting a potential downside of 19.10%. UnitedHealth Group has a consensus target price of $378.88, suggesting a potential downside of 5.44%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, analysts plainly believe UnitedHealth Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	4 Sell rating(s)	15 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.12
UnitedHealth Group	1 Sell rating(s)	7 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.72

Humana has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

UnitedHealth Group has a net margin of 2.68% compared to Humana's net margin of 0.82%. UnitedHealth Group's return on equity of 14.65% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
UnitedHealth Group	2.68%	14.65%	4.77%

92.4% of Humana shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 0.2% of Humana shares are held by insiders. Comparatively, 0.3% of UnitedHealth Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, UnitedHealth Group had 44 more articles in the media than Humana. MarketBeat recorded 58 mentions for UnitedHealth Group and 14 mentions for Humana. UnitedHealth Group's average media sentiment score of 1.15 beat Humana's score of 0.80 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	7 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
UnitedHealth Group	40 Very Positive mention(s)	8 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.2%. UnitedHealth Group pays an annual dividend of $8.84 per share and has a dividend yield of 2.2%. Humana pays out 37.9% of its earnings in the form of a dividend. UnitedHealth Group pays out 66.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has raised its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$137.20B	0.27	$1.19B	$9.35	32.63
UnitedHealth Group	$447.57B	0.81	$12.06B	$13.24	30.26

Summary

UnitedHealth Group beats Humana on 16 of the 20 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HUM vs. The Competition

Export

Metric	Humana	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$36.60B	$51.59B	$6.31B	$22.97B
Dividend Yield	1.29%	1.78%	2.79%	4.07%
P/E Ratio	32.63	23.01	21.03	28.29
Price / Sales	0.27	0.60	552.34	24.58
Price / Cash	12.27	22.92	42.94	25.11
Price / Book	1.96	2.48	9.83	4.73
Net Income	$1.19B	$1.46B	$3.55B	$1.07B
7 Day Performance	23.37%	3.77%	-0.52%	-1.11%
1 Month Performance	55.39%	18.50%	1.20%	1.36%
1 Year Performance	32.48%	-8.66%	41.25%	24.41%

Humana Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HUM Humana	3.6169 of 5 stars	$305.08 +3.3%	$246.83 -19.1%	+33.1%	$36.60B	$137.20B	32.63	67,060	Analyst Forecast Analyst Revision
CI Cigna Group	4.8843 of 5 stars	$279.53 -1.2%	$337.70 +20.8%	-0.5%	$73.66B	$274.90B	11.85	67,700	Positive News
CNC Centene	2.4333 of 5 stars	$53.59 +0.5%	$52.65 -1.8%	-0.5%	$26.46B	$198.10B	N/A	61,100
ELV Elevance Health	4.305 of 5 stars	$371.61 -0.3%	$384.58 +3.5%	+6.5%	$80.70B	$199.13B	15.81	97,100
MOH Molina Healthcare	2.2405 of 5 stars	$195.40 +1.4%	$169.60 -13.2%	-38.1%	$10.18B	$45.08B	57.81	19,000	Analyst Forecast Insider Trade Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HUM) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Summary

How does Humana compare to Centene?

Summary

How does Humana compare to Elevance Health?

Summary

How does Humana compare to Molina Healthcare?

Summary

How does Humana compare to UnitedHealth Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Is HUM or CI a better dividend stock?

Which has more risk & volatility, HUM or CI?

Is HUM or CI more profitable?

Which has higher earnings and valuation, HUM or CI?

Do analysts recommend HUM or CI?

Does the media prefer HUM or CI?

Do institutionals & insiders have more ownership in HUM or CI?

Summary

How does Humana compare to Centene?

Which has more risk and volatility, HUM or CNC?

Is HUM or CNC more profitable?

Which has stronger earnings and valuation, HUM or CNC?

Do analysts prefer HUM or CNC?

Does the media prefer HUM or CNC?

Do insiders and institutionals hold more shares of HUM or CNC?

Summary

How does Humana compare to Elevance Health?

Which has higher earnings and valuation, HUM or ELV?

Is HUM or ELV a better dividend stock?

Is HUM or ELV more profitable?

Which has more volatility and risk, HUM or ELV?

Do insiders & institutionals believe in HUM or ELV?

Do analysts prefer HUM or ELV?

Does the media refer more to HUM or ELV?

Summary

How does Humana compare to Molina Healthcare?

Does the media refer more to HUM or MOH?

Which has more risk & volatility, HUM or MOH?

Do institutionals & insiders believe in HUM or MOH?

Do analysts recommend HUM or MOH?

Which has stronger valuation and earnings, HUM or MOH?

Is HUM or MOH more profitable?

Summary

How does Humana compare to UnitedHealth Group?

Do analysts recommend HUM or UNH?

Which has more volatility and risk, HUM or UNH?

Is HUM or UNH more profitable?

Do insiders and institutionals have more ownership in HUM or UNH?

Does the media favor HUM or UNH?

Is HUM or UNH a better dividend stock?

Which has higher earnings and valuation, HUM or UNH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools